Michael J. McKelvey, Ph.D.
Executive Vice President, inVentiv Health
President, inVentiv Health Clinical Division
Mike McKelvey, Ph.D., leads the inVentiv Health Clinical Division, a global provider of comprehensive drug development services to the biopharmaceutical industry. Mike brings to his role nearly three decades of experience building successful global organizations in the pharmaceutical services, healthcare IT, life sciences, technology and global core laboratory industries. A results-oriented, hands-on leader, he oversees an organization of 6,500 professionals with deep therapeutic capabilities in Phase I-IV services.
As President of the Clinical Division, Mike builds dynamic teams that help clients exceed their development and financial goals.
Before joining inVentiv Health, he served as Executive Vice President and Chief Operating Officer at Aptiv Solutions, a global clinical development services company focused on adaptive clinical trial design. Aptiv Solutions was acquired by ICON in 2014. Prior to Aptiv Solutions, he was President and CEO and a board member of eResearchTechnology, Inc. (ERT), a multi-product provider of clinical research services. Prior to ERT, Dr. McKelvey led PAREXEL's PhaseII-IV clinical operations for the Americas, as well as their global data management and global biostatistics groups.
Throughout his career, Mike has developed a reputation for combining high-level strategic expertise with flawless execution.
Mike holds a Ph.D. and M.A. in Business Economics from the Wharton School at the University of Pennsylvania and an A.B. degree in Economics from Williams College.
Chief Financial Officer
Mr. Shimota’s unique combination of financial acumen and deep experience in project management for the engineering & construction sector business is invaluable to inVentiv Health Clinical which also performs project work. He brings nearly 30 years of professional experience in operational finance roles of increasing responsibility to inVentiv Health Clinical. Most recently, Mr Shimota served as CFO of Shaw Power, a division of The Shaw Group, Inc.
Chief ENTERPRISE BUSINESS Officer
Mr. Skalicky is Chief Enterprise Business Officer at inVentiv Health Clinical where he is responsible for enhancing the company's global market positioning. As the senior executive leading the global sales strategy across the early stage, II-IV and strategic resourcing business segments he is focused on securing broader strategic engagements with our clients. Mr. Skalicky has worked in the pharmaceutical industry for over eighteen years in both clinical operations and business development. His career at inVentiv Health Clinical began in 1997 where he was responsible for developing several strategic relationships with both biotechnology and large pharmaceutical organizations. He is a member of inVentiv Health Clinical executive leadership team and also serves on multiple governance teams that oversee broad scale client relationships. In addition, Mr. Skalicky is an Advisory Board Member for the Partnerships in Clinical Trials conference.